Skip Nav Destination
Issues
1 September 2021
-
Cover Image
Cover Image
Immune responses vary in colorectal cancers, which strongly influence prognosis. However, little is known about the variance in immune response within preinvasive lesions and how immune contexture may differ by clinicopathologic features associated with progression and recurrence in early carcinogenesis. In a study starting on page 885, Wallace and colleagues showed that immune infiltrate in lesions from the proximal colon (vs. distal colon or rectum) was associated with higher adaptive and innate immune cell expression. In contrast, increasing villous histology was associated with diminishing immune responses in cytokines and innate cells. These findings highlight the heterogeneity of the immune responses in preinvasive lesions, which may have implications for prevention strategies. The cover shows image analysis markups of cell detection and cell classification performed by Definiens Tissue Studio Algorithm on the immunofluorescently stained colon tissue with CD4 and RORC (Hoechst counterstain). The CD4 positive cells are painted in purple, RORC in cyan, CD4-RORC co-expressed cells in white and negative cells in green (Tissue Studio Library version 4.4.2; Definiens Inc., Carlsbad CA). - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Spotlight
Review
Research Briefs
Research Articles
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis
Charles M. Bowen; Lewins Walter; Ester Borras; Wenhui Wu; Zuhal Ozcan; Kyle Chang; Prashant V. Bommi; Melissa W. Taggart; Selvi Thirumurthi; Patrick M. Lynch; Laura Reyes-Uribe; Paul A. Scheet; Krishna M. Sinha; Eduardo Vilar
Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology
Kristin Wallace; Georges J. El Nahas; Christine Bookhout; Jessica E. Thaxton; David N. Lewin; Nana Nikolaishvili-Feinberg; Stephanie M. Cohen; J. Grant Brazeal; Elizabeth G. Hill; Jennifer D. Wu; John A. Baron; Alexander V. Alekseyenko
Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo
Carol J. Fabian; Christie A. Befort; Teresa A. Phillips; Jennifer L. Nydegger; Amy L. Kreutzjans; Kandy R. Powers; Trina Metheny; Jennifer R. Klemp; Susan E. Carlson; Debra K. Sullivan; Carola M. Zalles; Erin D. Giles; Stephen D. Hursting; Jinxiang Hu; Bruce F. Kimler
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.